13May 2023
Racial Inequality in Receipt of Medications for Opioid Use Disorder

Racial Inequality in Receipt of Medications for Opioid Use Disorder

A study examined racial and ethnic disparities in the use of medications for opioid use disorder (OUD) in the United States. The research utilized Medicare claims data from 2016 to 2019, focusing on Black, Hispanic, and White beneficiaries with OUD-related index events. The study found that Black patients had the lowest rates of receiving medications for OUD, with 12.7% receiving buprenorphine and 14.4% receiving naloxone after the index event. In comparison, White patients had the highest rates, with 23.3% receiving buprenorphine and 22.9% receiving naloxone. The findings indicate persistent racial and ethnic disparities in OUD treatment, despite regular contact with the healthcare system.

  • #family health

Like

Save

Share